Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy
SAS-CARE
2 other identifiers
interventional
246
3 countries
5
Brief Summary
The study aims to observe the short term effect (3-month) of sleep disordered breathing (SDB) on cardiovascular parameters, heart rate variability, endothelial function and surrogate markers of atherosclerosis after acute cerebrovascular events (ACE). The long-term effect (6-24-month) of Continuous Positive Airway Pressure (CPAP) on clinical vascular outcome, cardiovascular parameters, evolution of surrogate of atherosclerosis heart rate variability and endothelial function after ACE is observed over 24 months. A preventive effect of CPAP therapy on cerebro-vascular events in patients with moderate-severe obstructive SDB without sleepiness after ictus or transient ischaemic attack will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2010
Longer than P75 for phase_4
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2010
CompletedFirst Posted
Study publicly available on registry
April 2, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedOctober 26, 2015
October 1, 2015
5.8 years
April 1, 2010
October 23, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurence of new vascular events or death in stroke survivors (myocardial infarction, stroke, death) assessed by telephone or reported
New vascular events will be assessed by regular telephone interviews at 6,12 and 24 months after stroke
24 monts after stroke
Secondary Outcomes (3)
CPAP-Compliance measured by hours of usage
up to 24 months after stroke
Blood pressure profile (systolic mean, diastolic mean, max, min: general, day, night) measured in mmHg for every patient by ambulatory 24h-BP-devices in the acute stroke phase, after 3 months and after 12 months
up to 12 months after stroke
Blood pressure dipping measured by ambulatory 24h-BP-devices in the acute stroke phase, after 3 months and after 12 months
up to 12 months after stroke
Study Arms (3)
CPAP in sleepy patients with SDB
ACTIVE COMPARATORSDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10
no CPAP in non sleepy patients with SDB
NO INTERVENTIONSDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10
CPAP in non sleepy patients with SDB
ACTIVE COMPARATORSDB defined as AHI \>=20 Sleepy defined as Epworth Sleepiness Score \>=10
Interventions
Eligibility Criteria
You may qualify if:
- ≥ 35 years old and \< 75 years old
- with clinical diagnosis of TIA or ischemic stroke
- admitted in a Stroke Unit within 2 days from onset of symptoms
- or with TIA or ischemic stroke within the last 60-90 days
- signed Informed Consent
You may not qualify if:
- with unstable clinical situation (cardio-respiratory or life-threatening medical conditions)
- currently on CPAP or on CPAP during the last 3 months before stroke
- with non-ischemic events (intracerebral/subarachnoid haemorrhage)
- Patients with coma/stupor
- with borderline obstructive SDB (AHI 10-19)
- with any condition that interferes with the acceptance of CPAP treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. Claudio Bassettilead
- Swiss National Science Foundationcollaborator
- Schweizerische Herzstiftungcollaborator
- ResMedcollaborator
- Philips Respironicscollaborator
Study Sites (5)
University Hospital Münster
Münster, Germany
Dipartimento Neuroscienze, Ospedale Niguarda
Milan, Lombardy, I-20162, Italy
Inselspital, Universitätsklinik für Pneumologie
Bern, Canton of Bern, CH-3010, Switzerland
Ospedale San Giovanni
Bellinzona, Canton Ticino, CH-6500, Switzerland
Neurocenter of Southern Switzerland, Ospedale Civico
Lugano, Canton Ticino, CH-6900, Switzerland
Related Publications (8)
Bassetti C, Aldrich MS, Chervin RD, Quint D. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology. 1996 Nov;47(5):1167-73. doi: 10.1212/wnl.47.5.1167.
PMID: 8909424BACKGROUNDBassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999 Mar 15;22(2):217-23. doi: 10.1093/sleep/22.2.217.
PMID: 10201066BACKGROUNDMarin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53. doi: 10.1016/S0140-6736(05)71141-7.
PMID: 15781100BACKGROUNDBassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke. 2006 Apr;37(4):967-72. doi: 10.1161/01.STR.0000208215.49243.c3. Epub 2006 Mar 16.
PMID: 16543515BACKGROUNDMartinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, Soriano Y, Roman-Sanchez P, Illa FB, Canal JM, Duran-Cantolla J. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med. 2009 Jul 1;180(1):36-41. doi: 10.1164/rccm.200808-1341OC. Epub 2009 Apr 30.
PMID: 19406983BACKGROUNDPace M, Camilo MR, Seiler A, Duss SB, Mathis J, Manconi M, Bassetti CL. Rapid eye movements sleep as a predictor of functional outcome after stroke: a translational study. Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy138.
PMID: 30032306DERIVEDManconi M, Zavalko I, Cereda C, Pisarenco I, Ott S, Fulda S, Bassetti CL. Longitudinal polysomnographic assessment from acute to subacute phase in infratentorial versus supratentorial stroke. Cerebrovasc Dis. 2014;37(2):85-93. doi: 10.1159/000356323. Epub 2014 Jan 16.
PMID: 24435018DERIVEDCereda CW, Petrini L, Azzola A, Ciccone A, Fischer U, Gallino A, Gyorik S, Gugger M, Mattis J, Lavie L, Limoni C, Nobili L, Manconi M, Ott S, Pons M, Bassetti CL. Sleep-disordered breathing in acute ischemic stroke and transient ischemic attack: effects on short- and long-term outcome and efficacy of treatment with continuous positive airways pressure--rationale and design of the SAS CARE study. Int J Stroke. 2012 Oct;7(7):597-603. doi: 10.1111/j.1747-4949.2012.00836.x. Epub 2012 Jul 19.
PMID: 22812731DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudio Bassetti, Professor
Universitätsspital Bern (Inselspital) und Universität Bern
- STUDY CHAIR
Carlo Cereda, Capo CLinica
Neurocentre of Southern Switzerland, Ospedale Civico
- STUDY CHAIR
Sebastian Ott, MD
Pneumology, University Hospital, Bern
- STUDY CHAIR
Lino Nobili, Prof. MD
Neurology, Stroke Unit, Ospedale Niguarda, Milan, Italy
- STUDY CHAIR
Mauro Manconi, MD
Neurocentre of Southern Switzerland, Ospedale Civico
- STUDY CHAIR
Peter Young, Prof. MD
Universitätsklinik Münster, Zentrum für Schlafmedizin
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. med. Claudio Bassetti
Study Record Dates
First Submitted
April 1, 2010
First Posted
April 2, 2010
Study Start
July 1, 2010
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
October 26, 2015
Record last verified: 2015-10